article thumbnail

Risk of myocardial infarction and stroke following bloodstream infection: a population-based self-controlled case series

Open Heart

We aimed to determine the risk of myocardial infarction (MI) and stroke after BSI. We included adults with community-acquired BSI between 2010 and 2020. MI and stroke were determined from International Classification of Disease Version 10 coded admissions. The risk was similarly elevated for stroke. to 15.32)).

article thumbnail

Disparities in Race and Ethnicity Reporting and Representation for Clinical Trials in Stroke: 2010 to 2020

Journal of the American Heart Association

BackgroundRacial and ethnic minority groups are at a higher stroke risk and have poor poststroke outcomes. Trials conducted in the United States, related to stroke and enrolling participants ≥18 years, were considered eligible. fold increase in reporting between 2010 and 2020. Overall, 60.1% White patients represented 65.0%

Strokes 40
article thumbnail

Atrial Fibrillation’s Downstream Consequences

CardiacWire

A BMJ study out of Denmark provided alarming new insights into atrial fibrillation’s impact on patients’ future cardiovascular health, while highlighting the need to improve post-AFib heart failure and stroke prevention. in 2000-2010 to 30.9% The researchers analyzed 2000-2022 data from 3.5M overall, increasing from 24.2% in 2011-2022.

AFIB 105
article thumbnail

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Cardiovascular Diabetology

Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included. Trend analyses for the years 2010–2019 revealed improved one-year MACE in patients with diabetes and CAD (year 2019 vs. 2010; 0.90; 0.81-1.00,

article thumbnail

Utilization and Reporting of Patient-Reported Outcome Measures in Randomized Clinical Trials of Acute Stroke (2010–2020)

Stroke Journal

Stroke, Ahead of Print. There is growing interest in incorporating PROMs into clinical trials, but the extent that such measures are used in contemporary stroke trials is uncertain. Eligible studies were phase 2 or 3 trials that tested therapeutic interventions within 1 month of stroke onset.

Strokes 40
article thumbnail

Genetic Susceptibility Modifies Relationships Between Air Pollutants and Stroke Risk: A Large Cohort Study

Stroke Journal

Stroke, Volume 55, Issue 1 , Page 113-121, January 1, 2024. BACKGROUND:The extent to which genetic susceptibility modifies the associations between air pollutants and the risk of incident stroke is still unclear. These participants were followed up from the enrollment until the occurrence of stroke events or censoring of data.

Strokes 65
article thumbnail

Abstract 129: The evolution of focal cerebral arteriopathy (FCA) treatment and outcomes from 2010 to 2022: results of the VIPS studies

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page A129-A129, February 1, 2025. Background:The most common cause of arterial ischemic stroke (AIS) in previously healthy children, focal cerebral arteriopathy (FCA) can progress rapidly over days with worsening brain injury. Study neuroradiologist (M.W.) and pediatric vascular neurologist (H.J.F.)